The adverse effects of brand-name drug prescribing

被引：7

|

作者：

Flegel, Ken

机构：

来源：

CANADIAN MEDICAL ASSOCIATION JOURNAL | 2012年 / 184卷 / 05期

关键词：

D O I：

10.1503/cmaj.112160

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

收藏

页码：616 / 616

页数：1

相关论文

共 50 条

[21] Updated trends in US brand-name and generic drug competition
Grabowski, Henry
Long, Genia
Mortimer, Richard
Boyo, Ani
JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (09) : 836 - 844
[22] Brand-name Waters in Kyoto
Suzuki, Michihisa
SEN-I GAKKAISHI, 2012, 68 (09) : P278 - P279
[23] Brand-name versus generic
Copeland, Kennon R.
Boccuzzi, Stephen J.
HEALTH AFFAIRS, 2007, 26 (04) : 1198 - 1199
[24] Continuing trends in US brand-name and generic drug competition
Grabowski, Henry
Long, Genia
Mortimer, Richard
Bilginsoy, Mehmet
JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 908 - 917
[25] Brand-name drug costs expected to rise under CETA
Sibbald, Barbara
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2017, 189 (02) : E84 - E85
[26] A primer on brand-name prescription drug reimbursement in the United States
Hernandez, Inmaculada
Hung, Anna
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2024, 30 (01): : 99 - 106
[27] Brand-name drug companies continue to break research and development
Vogel, Lauren
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2010, 182 (11) : E519 - E519
[28] Exploration of approaches to adjusting brand-name drug prices in Mainland of China: based on comparison and analysis of some brand-name drug prices of Mainland and Taiwan, China
Weng Geng
Han Sheng
Pu Run
Wynn, Pan H. T.
Shi Luwen
CHINESE MEDICAL JOURNAL, 2014, 127 (12) : 2222 - 2228
[29] Reasons for switching from a generic to a brand-name drug:: example of allopurinol
Laroche, M. L.
Crepin, S.
Rolland, G.
Merle, L.
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 22 - 22
[30] Herbal products begin to attract the attention of brand-name drug companies
Cottrell, K
CANADIAN MEDICAL ASSOCIATION JOURNAL, 1996, 155 (02) : 216 - 219

← 1 2 3 4 5 →